A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation.
Lopez-Tapia, F., Lou, Y., Brotherton-Pleiss, C., Kuglstatter, A., So, S.S., Kondru, R.(2019) Bioorg Med Chem Lett 29: 1074-1078
- PubMed: 30857747 
- DOI: 10.1016/j.bmcl.2019.03.001
- Primary Citation of Related Structures:  
6HRP, 6HRT - PubMed Abstract: 
A seven-membered cyclic chiral analog of potent lead BTK inhibitor 1 was envisioned by structure-based design to lock the molecule into its bioactive conformation. For the elaboration of the seven-membered ring, compound 1 pyridone 6-position was substituted with the purpose to prevent formation of reactive metabolites ...